Multiomics News and Research

RSS

AGD Initiative Drives Progress in Drug Discovery with Sequencing of 250,000 Whole Genomes

Nashville Biosciences LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, and global DNA sequencing giant Illumina Inc. today announced that 250,000 whole genomes have been sequenced for the Alliance for Genomic Discovery (AGD) initiative.

22 Mar 2025

Identifying PRIMER Cells and their Role in Defense Signaling

A diverse population of immune cells that move from one organ to another and react to anything from cuts to colds to cancer is how human bodies protect themselves. However, this luxury is not available to plants.

9 Jan 2025

Single-Cell Analysis Sheds Light on Leukemia Cell Heterogeneity

Chromosomal instability plays a crucial role in the progression of cancer: it shapes the properties of tumor cells and drives the development of therapy resistance. Scientists from the German Cancer Research Center (DKFZ), the Heidelberg Stem Cell Institute HI-STEM and the European Molecular Biology Laboratory (EMBL) used state-of-the-art single-cell analysis methods to analyze the cellular heterogeneity of a specific form of acute myeloid leukemia.

26 Nov 2024

Novel Approach to Predict and Optimize CAR-T Cell Therapy

A significant turning point in the battle against cancer has been the recent development of CAR-T technology.

30 Oct 2024

A Computational Toolkit for Large-Scale Metabolomics Analysis

A computational workflow for analyzing massive data sets in metabolomics, the study of tiny chemicals found within cells, biofluids, tissues, and entire ecosystems has been developed by a research team led by experts at the University of California, Riverside.

23 Sep 2024

Comprehensive multi-omics approach reveals detailed insights into diabetes mechanisms

In a recent study published in Nature Communications, researchers utilized a comprehensive multi-omics approach, integrating genomic, proteomic, and metabolomic data from a diverse cohort, to uncover detailed molecular interactions and identify distinct diabetes subgroups.

20 Sep 2024

A Powerful New Tool for Biomedical Research

Scientists at Weill Cornell Medicine in Qatar (WCM-Q) have built a comprehensive molecular map of the human body and its complicated physiological processes by analyzing thousands of molecules found in 391 volunteers' blood, urine, and saliva samples.

12 Sep 2024

Study Identifies Genes for Healthier Rice with Low Glycemic Index and High Protein

A team of researchers at the International Rice Research Institute (IRRI) has identified genes and markers responsible for low glycemic index (GI) and high protein content in rice, using genetics and artificial intelligence classification methods.

2 Sep 2024

Dr. Bartek Rajwa of Purdue University Named Editor-in-Chief of “Cytometry Part A” Journal by the International Society for Advancement of Cytometry

The International Society for Advancement of Cytometry (ISAC) is pleased to announce the appointment of Dr. Bartek Rajwa as the new Editor-in-Chief of “Cytometry Part A – the Journal of Quantitative Cell Science.”

10 Feb 2024

Bio-Techne’s Advanced Cell Diagnostics (ACD) Sets New Standard in Spatial Biology with Protease-Free RNAscope Multiomics

Bio-Techne Corporation today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, has set a new standard with the development of a next-generation, protease-free RNAscope spatial multiomics workflow.

From Bio-Techne 30 Jan 2024

Lunaphore and Acd Revolutionize Spatial Biology Research With the Launch of the First Fully Automated, Same-Section, Hyperplex Multiomics Application

Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD), will launch the first fully automated spatial multiomics workflow with same-section hyperplex detection of RNA and protein biomarkers.

From Bio-Techne 25 Jan 2024

New State-of-the-Art Genomic Services Facility Opening in the UK

Azenta Life Sciences has selected Oxford, UK, a key European life sciences hub, as the location for its next GENEWIZ Multiomics and Synthesis Solutions site.

From Azenta Life Sciences 8 Dec 2023

A High-Throughput Assay for Identifying and Validating ECHS1 Enzyme Genetic Variants

The enzyme variations of mitochondrial enoyl-CoA hydratase short-chain 1 (ECHS1) are dysfunctional. In Japan, they are mostly responsible for mitochondrial disease.

19 May 2023

Glycine-Based Tripeptide Treats Severe Form of Fatty Liver Disease in Non-Human Primates

A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates -; bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests.

11 Apr 2023

Study uncovers differences in how AstraZeneca and Pfizer COVID-19 vaccines affect the immune system

A new Australian study led by SAHMRI and Flinders University has uncovered fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system.

23 Feb 2023

Studying the association between gut microbe and Parkinson’s disease

A new study by the University of Surrey suggests that Parkinson’s disease may begin in the gut and pass on to the brain.

From University of Surrey 18 Jan 2023

Large 'omics' dataset reveals a year in the biological life of Arctic Ocean

A major new project will help benchmark biodiversity change in the Arctic Ocean and guide conservation efforts by identifying unique species and assessing their extinction risk.

18 Oct 2022

The correlation between high facial similarity and shared DNA

DNA analysis and a collection of photographs of genetically unrelated lookalikes have shown that strong facial likeness is tied to shared genetic variations. The article is published in Cell Reports on August 23rd, 2022.

25 Aug 2022

Study uncovers genomic drivers and therapeutic vulnerabilities of transformed cutaneous T-cell lymphoma

Cutaneous T-cell lymphoma (CTCL) is an incurable, rare cancer of skin-homing T cells that is highly disfiguring and lethal at advanced stages.

2 Mar 2022

Paradigm4 joins the Tetra Partner Network to leverage Tetra Data into high-performing analytical computing applications for pharmaceutical customers

TetraScience, the R&D Data Cloud company, announced today that Paradigm4, an integrated scientific data analytics company, has joined the Tetra Partner Network so that pharmaceutical customers can accelerate research decision-making using Tetra Data as a foundation for analytical computing.

From TetraScience, Inc. 18 Jan 2022